Illumina Competitors and Similar CompaniesClear all

Illumina's competitors and similar companies include QIAGEN, Luminex, BGI Genomics, Thermo Fisher Scientific, Bruker and Natera.

	Illumina Illumina is a company that develops, manufactures, and markets life science tools and sequencing and array-based integrated systems for genetic and genomic analysis.	QIAGEN QIAGEN (formerly known as Diagen) is a company that provides sample technology solutions.	Luminex Luminex is a company that develops and manufactures multiplexing technologies for researchers and clinicians.	BGI Genomics BGI Genomics (华大基因, 深圳华大基因股份有限公司) is a company offering genomic sequencing and proteomic services.	Thermo Fisher Scientific Thermo Fisher Scientific is a biotechnology company engaged in service science.	Bruker Bruker is a company that develops, manufactures, and distributes scientific instruments and analytical and diagnostic services.	Natera Natera (formerly known as Gene Security Network) is a diagnostics company with proprietary molecular and bioinformatics technology.
Founding Date	Founding Date 1998	Founding Date 1984	Founding Date 1998	Founding Date 1999	Founding Date 1956	Founding Date 1960	Founding Date 2004
Type	Type Public	Type Public	Type Subsidiary	Type Public	Type Public	Type Public	Type Public
Tags	Tags Manufacturing & Industrial electronics life sciences medical devices	Tags Healthcare clinical research medical devices	Tags Manufacturing & Industrial application software biotech drug monitoring life sciences medical diagnostics medtech platform	Tags Healthcare biotech genetics medical diagnostics oncology	Tags Healthcare Manufacturing & Industrial biotech chemicals life sciences medical diagnostics medtech	Tags Technology biotech clinical research medical devices medical diagnostics medical imaging	Tags Healthcare genetics healthtech medical diagnostics women's health
Locations	Locations San Diego, US HQ Melbourne, AU Sao Paulo, BR Beijing, CN Shanghai, CN Shanghai, CN Évry, FR see more	Locations Venlo, NL HQ Clayton, AU Antwerpen, BE São Paulo, BR Toronto, CA Beijing, CN Guangzhou, CN see more	Locations Austin, US HQ Toronto, CA Shanghai, CN Hong Kong, HK Saluggia, IT Tokyo, JP 's Hertogenbosch, NL see more	Locations Shenzhen, CN HQ Brisbane, AU Copenhagen, DK Addis Ababa, ET Hong Kong, HK Budapest, HU Kobe, JP see more	Locations Waltham, US HQ Buenos Aires, AR Buenos Aires, AR Buenos Aires, AR Adelaide Airport, AU Brendale, AU Canberra, AU see more	Locations Billerica, US HQ Preston, AU Wien, AT Kontich, BE Atibaia, BR Milton, CA Beijing, CN see more	Locations Austin, US HQ San Carlos, US
Employees	Employees 10,5908% decrease	Employees 5,7002% decrease	Employees 1,0101% decrease	Employees 3,752	Employees 125,0002% increase	Employees 9,70714% increase	Employees 3,28211% increase
Valuation ($)	Valuation ($) 23.3 b	Valuation ($) 9.3 b	Valuation ($) N/A	Valuation ($) 2.7 b	Valuation ($) 209.2 b	Valuation ($) 8.9 b	Valuation ($) 15.4 b
Financial
Revenue (est.)	Revenue (est.) $4.4b (FY, 2024)	Revenue (est.) $2b (FY, 2024)	Revenue (est.) $417.4m (FY, 2020)	Revenue (est.) ¥4.3b (FY, 2023)	Revenue (est.) $42.9b (FY, 2024)	Revenue (est.) $3.4b (FY, 2024)	Revenue (est.) $1.7b (FY, 2024)
Cost of goods	Cost of goods $1.5b (FY, 2024)	Cost of goods $640.7m (FY, 2024)	Cost of goods $169.5m (FY, 2020)	Cost of goods ¥2.2b (FY, 2023)	Cost of goods $25.2b (FY, 2024)	Cost of goods $1.7b (FY, 2024)	Cost of goods N/A
Gross profit	Gross profit $2.9b (FY, 2024)	Gross profit $1.3b (FY, 2024)	Gross profit $247.9m (FY, 2020)	Gross profit ¥2.2b (FY, 2023)	Gross profit $17.7b (FY, 2024)	Gross profit $1.6b (FY, 2024)	Gross profit N/A
Net income	Net income ($1.2b) (FY, 2024)	Net income $83.6m (FY, 2024)	Net income $15.2m (FY, 2020)	Net income ¥93.7m (FY, 2023)	Net income $6.3b (FY, 2024)	Net income $113.8m (FY, 2024)	Net income ($190.4m) (FY, 2024)
Operating ⚠
Backlog	Backlog $1b (FY, 2022)	Backlog N/A	Backlog N/A	Backlog N/A	Backlog N/A	Backlog $2.1b (FY, 2022)	Backlog N/A
Countries	Countries N/A	Countries N/A	Countries N/A	Countries 100 (FY, 2022)	Countries 70 (FY, 2023)	Countries N/A	Countries N/A
Facilities Leased, sq. ft.	Facilities Leased, sq. ft. 3 (FY, 2022)	Facilities Leased, sq. ft. N/A	Facilities Leased, sq. ft. N/A	Facilities Leased, sq. ft. N/A	Facilities Leased, sq. ft. N/A	Facilities Leased, sq. ft. 445.7 k (FY, 2022)	Facilities Leased, sq. ft. 272 k (FY, 2021)
Remaining Performance Obligations	Remaining Performance Obligations N/A	Remaining Performance Obligations $54.5m (FY, 2022)	Remaining Performance Obligations N/A	Remaining Performance Obligations N/A	Remaining Performance Obligations $25.3b (Q3, 2024)	Remaining Performance Obligations $2.3b (FY, 2022)	Remaining Performance Obligations N/A
Funding
Total funding raised	Total funding raised $ 28m	Total funding raised $ 4m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 500m	Total funding raised $ 24.5m	Total funding raised $ 154.1m